We develop novel therapeutics based on our nanoparticle platform (Pdx-NPTM) for co-delivery of siRNA, drugs, vaccines, and/or immunotherapies. We are a leader in the field of advanced functional materials and nanotechnology (with over 60 peer-reviewed publications and 6 journal covered articles). Founded in 2010 as a start-up from the Biomedical Engineering Department (BME) at Oregon Health and Science University (OHSU) School of Medicine PDX Pharma has raised about $13.5 million of financing to date ($10M is non-dilutive) and is currently seeking private investment to conduct clinical trials of its first drug candidates, ARAC-02 and AIRISE-02. To improve human health and medicine through innovative therapies for various forms of cancer. We specialize in the development of novel cancer therapeutics by combining nanotechnology and cancer systems biology. We also specialize in the development of animal models of cancer for in vivo efficacy and safety evaluation of our drug candidates. In collaboration with the Knight Cancer Institute of OHSU, we also have strong expertise in combination therapies and precision medicine in cancer. PDX Pharmaceuticals (DBA Raksa Therapeutics) is a biopharmaceutical company leveraging novel nano- technology and cancer systems biology to develop next-generation combi- nation immunotherapies for cancer.
This company is:
Verified
PDX Pharma’s ARAC-02 drug candidate has been selected into the Nanotechnology Characterization Lab (NCL)’s collaboration and characterization program. | PDX Pharmaceuticals
PDX Pharma’s ARAC-02 drug candidate has been selected into the Nanotechnology Characterization Lab (NCL)’s collaboration and characterization program. | pdx news | PDX Pharma awarded two-year $1.87M phase II SBIR grant from the National Cancer Institute (NCI) for the development of ARAC-02, a novel lung cancer treatment | PDX Pharma’s ARAC-02 drug candidate has been selected into the Nanotechnology Characterization Lab (NCL)’s collaboration and characterization program. | PDX Pharma won two Corporate Philanthropy Awards
View all products
Keywords
Industries
Where is Pdx Pharmaceuticals located?
The company Pdx Pharmaceuticals is located in Portland, Oregon, United States. It's worth noting that the company may has more corporate locations
How many employees does Pdx Pharmaceuticals approximately have?
As of the latest available information Pdx Pharmaceuticals has around 11-50 employees worldwide.
When was Pdx Pharmaceuticals founded?
Pdx Pharmaceuticals was founded in 2010
In which industries does Pdx Pharmaceuticals mainly work?
The company Pdx Pharmaceuticals has it's main focus in the industries of Other
NexusPharma
United States
11-50 Employees
2004
PDC Therapeutics
Switzerland
1-10 Employees
2020
Nanotech Pharma Inc.
United States
1-10 Employees
2018
Oncology Pharma
United States
1993
NanoMedTrix LLC
United States
1-10 Employees
2012
NTT Biopharma 奈力生醫
Taiwan
1-10 Employees
2016
SciTech Development LLC
United States
Raadysan Biotech, Inc.
United States
1-10 Employees
2012
Topics which have been searched by others and may be interesting for you:
